Diabetes drug could hold promise for lung cancer patients

Ever since discovering a decade ago that a gene altered in lung cancer regulated an enzyme used in therapies against diabetes, one medical researcher has wondered if drugs originally designed to treat metabolic diseases could also work against cancer.

Read the whole article on Science Daily

More from Science Daily